Streetbeat News

Revenues

ELV

Elevance Health (NYSE:ELV) has received 7 analyst ratings in the last three months, all somewhat bullish, with a recent shift in sentiment and price targets. The average 12-month price target is now $556.29, down from $562.67. Elevance Health, a leading U.S. health insurer and the largest provider of Blue Cross Blue Shield branded coverage, faces revenue challenges with a -0.47% decline but shows strong profitability and financial health indicators.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 2:00 pm

IPGP

Analysts have provided diverse opinions on IPG Photonics (NASDAQ:IPGP), with 4 bullish ratings unchanged over the past quarter. The average 12-month price target was adjusted to $122.5, a 2.0% decrease. Financial indicators show IPG Photonics has a strong market position, with significant market capitalization, exceptional net margin, and above-average ROE and ROA, despite a revenue decline of -13.64% over the last 3 months.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 2:00 pm

GFS

GLOBALFOUNDRIES (NASDAQ:GFS) has received mixed analyst ratings over the last three months, with a shift towards a more bullish stance in the last 30 days. The average 12-month price target for GFS has been adjusted to $65.2, down from $69.67, reflecting a 6.42% decrease. Analysts from firms including Cantor Fitzgerald, Susquehanna, JP Morgan, and B of A Securities have updated their ratings and price targets, indicating varied expectations for the company's performance. GLOBALFOUNDRIES, a leading semiconductor manufacturer, faces challenges in market capitalization, revenue growth, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 2:00 pm

ULTA

Ulta Beauty (NASDAQ:ULTA) has been analyzed by 13 analysts, showing a mix of bullish to bearish sentiments. The average 12-month price target is $529.77, up 5.3% from the previous target. Analyst actions include ratings adjustments and price target changes, reflecting recent company performance and market conditions. Ulta Beauty, with 1,355 stores and a partnership with Target, is a leading beauty retailer in the U.S. Financial indicators such as market capitalization, revenue growth, net margin, ROE, and ROA surpass industry averages, indicating a strong market position and financial performance.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 2:00 pm

IPX

IperionX is advancing towards commercial-scale titanium production with significant progress at its Virginia Titanium Manufacturing Campus. The company has received the first $2.4M from a $12.7M Department of Defense grant for the Phase I ramp-up. The HAMR titanium furnace, a key asset, has passed factory tests and is expected to be installed in Q2 2024, with titanium production starting mid-year. This initiative aims to revitalize the U.S. titanium supply chain, offering high-performance, low-cost titanium products with lower environmental impacts.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:44 pm

EMN

Eastman has entered into a long-term agreement with Nord Pal Plast, part of the Dentis Group, to supply 30,000 metric tons of product per year. This deal signifies a significant commitment between Eastman and Nord Pal Plast and may influence Eastman's production volume and revenue.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:40 pm

CREV

Carbon Revolution plc (NASDAQ:CREV), a leading manufacturer of lightweight automotive carbon fiber wheels, reported a 177% YoY increase in fiscal Q2 revenue to $14.8M and a 42% increase in annual revenue to $40.3M for the year ended December 31, 2023. The growth is attributed to new program wins moving into production and the expansion of existing programs.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:15 pm

BGC

BGC Group reported Q4 2023 adjusted EPS of $0.21, surpassing the $0.20 estimate, but its sales of $516.76M fell short of the $554.60M estimate, marking an 18.38% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:07 pm

SANW

S&W Seed Company projects its FY24 revenue to be in the range of $76M-$82M, which is around the current estimate of $78.432M.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:05 pm

VSTE

Vast Renewables Limited (Vast) and Mabanaft have secured up to AUD $40 million in funding for the SM1 solar methanol plant, aimed at decarbonizing shipping by producing green methanol using concentrated solar thermal power (CSP) technology. The funding, provided by the Australian Renewable Energy Agency (ARENA) and Projektträger Jülich (PtJ) on behalf of the German government, supports the German-Australian Hydrogen Innovation and Technology Incubator (HyGATE) program. SM1, powered by Vast's CSP v3.0 technology, aims to produce up to 7,500 tonnes of green methanol annually, potentially reducing green fuel production costs by up to 40% and creating hundreds of jobs.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:04 pm